ATXI
Avenue Therapeutics, Inc. Common Stock
ATXI
ATXI
Delisted
ATXI was delisted on the 18th of March, 2025.
14 hedge funds and large institutions have $157K invested in Avenue Therapeutics, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 1 closing their positions.
Holders
14
Holders Change
+2
Holders Change %
+16.67%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$32.7K |
| 2 |
TSS
2
Two Sigma Securities
New York
|
$10.2K |
| 3 |
TRCT
3
Tower Research Capital (TRC)
New York
|
$4.86K |
| 4 |
4
Osaic Holdings
Scottsdale,
Arizona
|
$353 |
Top Sellers
| 1 |
SM
1
Sabby Management
Miami Beach,
Florida
|
$0 |
| 2 |
SAM
2
Shikiar Asset Management
New York
|
$9K |
| 3 |
3
Bank of New York Mellon
New York
|
$36.5K |
| 4 |
4
Morgan Stanley
New York
|
$195 |
| 5 |
5
BlackRock
New York
|
$1.32K |
